Article Text

Download PDFPDF
Validity of neurodevelopmental outcomes of children born very preterm assessed during routine clinical follow-up in England
  1. Hilary S Wong1,2,
  2. Frances M Cowan2,
  3. Neena Modi2
  4. On behalf of the Medicines for Neonates Investigator Group
    1. 1 Department of Paediatrics, University of Cambridge, Cambridge, UK
    2. 2 Section of Neonatal Medicine, Department of Medicine, Chelsea and Westminster Hospital Campus, Imperial College London, London, UK
    1. Correspondence to Dr Hilary S Wong, Department of Paediatrics, University of Cambridge, Box 116, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK; syw27{at}medschl.cam.ac.uk

    Footnotes

    • Contributors HSW, FMC and NM contributed to the conception and design of the study and analysis and interpretation of data. HSW drafted the manuscript; FMC and NM reviewed it critically for important intellectual content. All authors read and approved the final manuscript.

    • Funding This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Grant Reference Number RP-PG-0707-10010). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.

    • Competing interests None declared.

    • Ethics approval Royal Free Hospital Research Ethics Committee (REC 10/H0720/35).

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Data sharing statement All available data can be obtained by contacting the corresponding author.

    • Collaborators Medicines for Neonates Investigators are Deborah Ashby (Imperial College London), Peter Brocklehurst (University of Birmingham), Kate Costeloe (Queen Mary University of London), Elizabeth Draper (University of Leicester), Jacquie Kemp (London), Azeem Majeed (Imperial College London), Neena Modi (Imperial College London), Stavros Petrou (University of Warwick), Alys Young (University of Manchester), Jane Abbott and Zoe Chivers (Bliss, London).

    • Presented at This study was presented at the British Association of Perinatal Medicine section of the Royal College of Paediatrics and Child Health 2015 Annual Conference in Birmingham, UK.

    View Full Text

    Statistics from Altmetric.com

    Footnotes

    • Contributors HSW, FMC and NM contributed to the conception and design of the study and analysis and interpretation of data. HSW drafted the manuscript; FMC and NM reviewed it critically for important intellectual content. All authors read and approved the final manuscript.

    • Funding This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Grant Reference Number RP-PG-0707-10010). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.

    • Competing interests None declared.

    • Ethics approval Royal Free Hospital Research Ethics Committee (REC 10/H0720/35).

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Data sharing statement All available data can be obtained by contacting the corresponding author.

    • Collaborators Medicines for Neonates Investigators are Deborah Ashby (Imperial College London), Peter Brocklehurst (University of Birmingham), Kate Costeloe (Queen Mary University of London), Elizabeth Draper (University of Leicester), Jacquie Kemp (London), Azeem Majeed (Imperial College London), Neena Modi (Imperial College London), Stavros Petrou (University of Warwick), Alys Young (University of Manchester), Jane Abbott and Zoe Chivers (Bliss, London).

    • Presented at This study was presented at the British Association of Perinatal Medicine section of the Royal College of Paediatrics and Child Health 2015 Annual Conference in Birmingham, UK.

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.